Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > University of Twente spin-off company develops spectacularly fast virus detector

Abstract:
Imagine being able to detect in just a few minutes whether someone is infected with a virus. This has now become a reality, thanks to a new ultra-sensitive detector that has been developed by Ostendum, a spin-off company of MESA+ Institute for Nanotechnology/University of Twente. The company has just completed the first prototype and expects to be able to introduce the first version of the detector onto the market in late 2010. Not only does the detector carry out measurements many times faster than do standard techniques, it is also portable, so it can be used anywhere. Ostendum's Aurel Ymeti (R&D director), Alma Dudia (Senior Researcher) and Paul Nederkoorn (CEO) claim that if they had the right antibodies to the swine flu at their disposal, they would be able to highlight the presence of the virus within five minutes. In addition to viruses, the device is also able to pick up bacteria, proteins and DNA molecules.

University of Twente spin-off company develops spectacularly fast virus detector

The Netherlands | Posted on May 28th, 2009

Following the outbreak of swine flu, the issue of finding a means of detecting quickly and simply whether someone is infected with a virus is again very much on the agenda. It is important to be able to do so as soon as possible in order to prevent the virus from spreading further. However, the techniques that are currently available do not yield results for several hours or even days. Moreover, the tests cannot be carried out without a laboratory or trained personnel.

Researchers at Ostendum, a spin-off company of the University of Twente, have developed a portable device that can show in five minutes whether or not a person is infected with a particular virus. The system is able to detect not only viruses, but also specific bacteria, proteins and DNA molecules, an increased or reduced concentration of which in a person's saliva may be an indication that they have one illness or another.

The only thing needed by the Ostendum detection method is a sample of saliva, blood or another body fluid from the person being tested and the availability of a specific receptor (i.e. a substance that binds with a specific micro-organism or biological substance). For example, in the case of a virus, a specific antibody served as a receptor on the chip and such antibody to that virus has to be available in order to be able to apply the underlying detection method.

Prototype

Ymeti demonstrated during his doctoral research in 2007 that the principle behind the detector worked. At the time, he used a fairly sizeable laboratory set-up. The Ostendum company was subsequently founded, in 2008, in order to develop the principle into a marketable product.

This week, the company completed the first prototype of the device, and it is presently working on two others. The three prototypes are undergoing practical tests, in a collaboration involving the Laboratorium Microbiologie Twente Achterhoek and the Zwanenberg Food Group. Ostendum will then make further improvements to the design of the device on the basis of the test results, and expects to have the first device ready for introduction to the marketplace in late 2010.

How it works

The device consists of two parts: a lab-on-a-chip-system and a portable detector. A lab-on-a-chip is a miniature laboratory the size of a chip. The chip contains tiny channels that are coated with receptors. The blood or saliva sample is transported to the channels with the help of a fluid system. Substances from the saliva or blood can then bind with the receptors on the chip. Light from a laser is guided through the channels. If any of the substances binds with the receptors in any of the channels, this will alter the phase of the light. Such a change will manifest itself in the interference pattern, and is a fingerprint of any viruses present, for example, or biomarkers. The method is highly sensitive: it is possible to measure the binding of a single virus particle.

####

Contacts:
The contact persons for the press are Aurel Ymeti (tel. +31 (0)53 489 3870 - Ostendum R&D) or Joost Bruysters (tel. +31 (0)53 489 2773 – for communication with the University of Twente).

Copyright © University of Twente

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Keeping electric car design on the right road: A closer look at the life-cycle impacts of lithium-ion batteries and proton exchange membrane fuel cells December 9th, 2016

Further improvement of qubit lifetime for quantum computers: New technique removes quasiparticles from superconducting quantum circuits December 9th, 2016

Chemical trickery corrals 'hyperactive' metal-oxide cluster December 8th, 2016

Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D: Up-close, real-time, chemical-sensitive 3-D imaging offers clues for reducing cost/improving performance of catalysts for fuel-cell-powered vehicles and other applications December 8th, 2016

Possible Futures

Keeping electric car design on the right road: A closer look at the life-cycle impacts of lithium-ion batteries and proton exchange membrane fuel cells December 9th, 2016

Further improvement of qubit lifetime for quantum computers: New technique removes quasiparticles from superconducting quantum circuits December 9th, 2016

Researchers peer into atom-sized tunnels in hunt for better battery: May improve lithium ion for larger devices, like cars December 8th, 2016

Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D: Up-close, real-time, chemical-sensitive 3-D imaging offers clues for reducing cost/improving performance of catalysts for fuel-cell-powered vehicles and other applications December 8th, 2016

Nanomedicine

Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results December 7th, 2016

Fast, efficient sperm tails inspire nanobiotechnology December 5th, 2016

Journal Nanotechnology Progress International (JONPI) Volume 6, issue 2 coming out soon! December 5th, 2016

UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016

Sensors

Shape matters when light meets atom: Mapping the interaction of a single atom with a single photon may inform design of quantum devices December 4th, 2016

Deep insights from surface reactions: Researchers use Stampede supercomputer to study new chemical sensing methods, desalination and bacterial energy production December 2nd, 2016

Tip-assisted chemistry enables chemical reactions at femtoliter scale November 16th, 2016

'Back to the Future' inspires solar nanotech-powered clothing November 15th, 2016

Announcements

Keeping electric car design on the right road: A closer look at the life-cycle impacts of lithium-ion batteries and proton exchange membrane fuel cells December 9th, 2016

Further improvement of qubit lifetime for quantum computers: New technique removes quasiparticles from superconducting quantum circuits December 9th, 2016

Researchers peer into atom-sized tunnels in hunt for better battery: May improve lithium ion for larger devices, like cars December 8th, 2016

Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D: Up-close, real-time, chemical-sensitive 3-D imaging offers clues for reducing cost/improving performance of catalysts for fuel-cell-powered vehicles and other applications December 8th, 2016

Nanobiotechnology

Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results December 7th, 2016

Fast, efficient sperm tails inspire nanobiotechnology December 5th, 2016

Deep insights from surface reactions: Researchers use Stampede supercomputer to study new chemical sensing methods, desalination and bacterial energy production December 2nd, 2016

Nanobiotix Provides Update on Global Development of Lead Product NBTXR3: Seven clinical trials across the world: More than 2/3 of STS patients recruited in the “act.in.sarc” Phase II/III trial: Phase I/II prostate cancer trial now recruiting in the U.S. November 28th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project